These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7004857)

  • 1. Effect of down-regulation of insulin receptors on receptor-antibody binding.
    Blackard WG; Sherrod J; Ludeman C
    Endocrinology; 1981 Feb; 108(2):478-83. PubMed ID: 7004857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Anti-Insulin Receptor Antibody on Insulin Dissociation from IM-9 lymphocytes.
    Blackard WG; Ludeman CH
    Horm Metab Res; 1981 Sep; 13(9):480-3. PubMed ID: 7028593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes.
    Flier JS; Kahn CR; Jarrett DB; Roth J
    J Clin Invest; 1977 Oct; 60(4):784-94. PubMed ID: 893677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin receptor: characterization and regulation using insulin-antiinsulin antibody complexes as a probe for flow cytometry.
    Maron R; Kahn CR
    J Clin Endocrinol Metab; 1985 May; 60(5):1004-11. PubMed ID: 3884645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-receptor antibodies mimic the effect of insulin to down-regulate insulin receptors in cultured human lymphoblastoid (IM-9) cells.
    Taylor SI; Marcus-Samuels B
    J Clin Endocrinol Metab; 1984 Jan; 58(1):182-6. PubMed ID: 6358243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor binding and degradation in IM-9 cultured human lymphocytes - importance of extracellular degradation.
    Misbin RI; Mehl TD
    J Endocrinol Invest; 1980; 3(1):77-81. PubMed ID: 6989890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanadate down-regulates cell surface insulin and growth hormone receptors and inhibits insulin receptor degradation in cultured human lymphocytes.
    Torossian K; Freedman D; Fantus IG
    J Biol Chem; 1988 Jul; 263(19):9353-9. PubMed ID: 3288633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of a monoclonal antibody to the insulin receptor with receptors for insulin-like growth factors.
    Roth RA; Maddux B; Wong KY; Styne DM; Van Vliet G; Humbel RE; Goldfine ID
    Endocrinology; 1983 May; 112(5):1865-7. PubMed ID: 6299712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the insulin receptor by anti-receptor antibodies and flow cytometry.
    Maron R; Jackson RA; Jacobs S; Eisenbarth G; Kahn CR
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7446-50. PubMed ID: 6390439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
    Vigneri R; Pezzino V; Wong KY; Goldfine ID
    J Clin Endocrinol Metab; 1982 Jan; 54(1):95-100. PubMed ID: 7033271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of insulin receptor kinase activity by insulin mimickers and an insulin antagonist.
    Roth RA; Cassell DJ; Maddux BA; Goldfine ID
    Biochem Biophys Res Commun; 1983 Aug; 115(1):245-52. PubMed ID: 6351861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of insulin receptors in primary cultures of R3230 AC rat mammary adenocarcinoma cells.
    Sorge LK; Hilf R
    Endocrinology; 1982 Apr; 110(4):1155-63. PubMed ID: 7037367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular potassium depletion in IM-9 lymphocytes suppresses the slowly dissociating component of human growth hormone binding and the down-regulation of its receptors but does not affect insulin receptors.
    Ilondo MM; Courtoy PJ; Geiger D; Carpentier JL; Rousseau GG; De Meyts P
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6460-4. PubMed ID: 3018733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the insulin receptor by a monoclonal anti-receptor antibody. Evidence that receptor down regulation can be independent of insulin action.
    Roth RA; Maddux BA; Cassell DJ; Goldfine ID
    J Biol Chem; 1983 Oct; 258(20):12094-7. PubMed ID: 6355081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of mitogen receptor occupancy and modulation of mitogen receptor exposure: possible mechanisms for the regulation of cell growth.
    Perdue JF; Raizada MK
    Prog Clin Biol Res; 1976; 9():49-64. PubMed ID: 193133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin receptor regulation in cultured human tumor cells.
    Mountjoy KG; Holdaway IM; Finlay GJ
    Cancer Res; 1983 Oct; 43(10):4537-42. PubMed ID: 6349794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of insulin binding by concanavalin-A.
    Blackard WG; Small E; Luderman C
    Metabolism; 1980 Jul; 29(7):691-7. PubMed ID: 6991862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation.
    Forsayeth JR; Montemurro A; Maddux BA; DePirro R; Goldfine ID
    J Biol Chem; 1987 Mar; 262(9):4134-40. PubMed ID: 2435731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action.
    Di Paolo S; Giorgino R
    J Clin Endocrinol Metab; 1991 Sep; 73(3):650-7. PubMed ID: 1874939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of chloroquine on concanavalin A internalization into cell monolayer culture.
    Sorimachi K; Yasumura Y; Okayasu T
    Jpn J Exp Med; 1985 Apr; 55(2):53-9. PubMed ID: 4046209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.